<- Go Home
YD Bio Limited
YD Bio Limited a biopharmaceutical company focuses on blood-based cancer detection and develops stem cell- and exosome-based therapeutics to transform the treatment of spectrum of diseases with unmet medical needs. The company is based in Taipei, Taiwan.
Market Cap
$373.4M
Volume
5.8K
Cash and Equivalents
$3.1M
EBITDA
-$1.4M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$155.4K
Profit Margin
30.44%
52 Week High
$25.00
52 Week Low
$4.73
Dividend
N/A
Price / Book Value
1.16
Price / Earnings
-4.12
Price / Tangible Book Value
1.96
Enterprise Value
$370.3M
Enterprise Value / EBITDA
-276.31
Operating Income
-$1.5M
Return on Equity
42.69%
Return on Assets
-25.43
Cash and Short Term Investments
$3.1M
Debt
$22.3K
Equity
$6.6M
Revenue
$510.4K
Unlevered FCF
-$3.9M
Sector
Biotechnology
Category
N/A